Share this article
Share this article
ResearchAndMarkets.com s offering.
The global interventional oncology market size is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2020, at a CAGR of 6.8%.
Factors such as the technological advancements in the market are propelling the growth of the interventional oncology market. Additionally, rising cases of surgeries, investments from both private and public sectors are having effects on the growth of the interventional oncology market. However, unfavorable reimbursement scenarios in some countries are hampering the growth of this market.
The recent COVID-19 global pandemic has also impacted the interventional oncology market. Demand from the main end-users has declined as key regions and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.